Trials / Unknown
UnknownNCT02890108
Effect of Consumption of Non Caloric Sweeteners and Insulin Sensibility
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Instituto de Nutrición y Tecnología de los Alimentos · Academic / Other
- Sex
- All
- Age
- 25 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study will compare the effect of acute consumption of two carbonated drinks, sweetened with sugar or with non-caloric sweeteners, over the insulin response of healthy adults who normally consumed foods or drinks that contain non-caloric sweeteners
Detailed description
During the last decades there has been a sustained increase in prevalence of overweight and obesity and, along with it, of chronic noncommunicable diseases. There have been addressed various management strategies, including sugar replacement for Non-caloric Artificial Sweeteners (NAS). Nevertheless, in several cohort studies it has found the opposite effect, it has observed associations between the consumption of NAS with greater weight gain and increased risk of type 2 diabetes and metabolic syndrome. In clinical trials, in both humans and mice, there has been greater association with glucose intolerance, being 3 possible mechanisms: 1) dysbiosis of the intestinal microbiota; 2) altered regulation of appetite cephalic phase and secretion of glucagon like peptide-1 (GLP-1); and 3) increased intestinal glucose absorption via increased Sodium-Glucose Linked Transporter-1 (SGLT-1) and Glucose transporter 2 (GLUT2), transporters to glucose absorption. In the following review the major findings in the literature regarding the consumption of NAS and its deleterious effects on human health will be studied.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Sugar sweetened beverages | 350 cc (1 can) of sugar sweetened beverage |
| DIETARY_SUPPLEMENT | Artificially sweetened beverages | 350 cc (1 can) of artificially sweetened beverage |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2016-09-01
- Completion
- 2016-10-01
- First posted
- 2016-09-07
- Last updated
- 2016-09-07
Locations
1 site across 1 country: Chile
Source: ClinicalTrials.gov record NCT02890108. Inclusion in this directory is not an endorsement.